9.59
-0.15(-1.54%)
Currency In USD
| Previous Close | 9.74 |
| Open | 9.77 |
| Day High | 9.93 |
| Day Low | 9.44 |
| 52-Week High | 19.71 |
| 52-Week Low | 2.21 |
| Volume | 1.04M |
| Average Volume | 2.81M |
| Market Cap | 669.52M |
| PE | -1.85 |
| EPS | -5.18 |
| Moving Average 50 Days | 5.73 |
| Moving Average 200 Days | 8.78 |
| Change | -0.15 |
If you invested $1000 in Phathom Pharmaceuticals, Inc. (PHAT) since IPO date, it would be worth $389.84 as of July 01, 2025 at a share price of $9.59. Whereas If you bought $1000 worth of Phathom Pharmaceuticals, Inc. (PHAT) shares 5 years ago, it would be worth $297.83 as of July 01, 2025 at a share price of $9.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
GlobeNewswire Inc.
Jun 23, 2025 11:59 AM GMT
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appoi
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
GlobeNewswire Inc.
Jun 16, 2025 12:00 PM GMT
FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
GlobeNewswire Inc.
Jun 06, 2025 4:27 PM GMT
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen Petition filed on December 11, 2024 and communicated